Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation
Abstract:
This document provides methods and materials involved in identifying mammals having lung adenocarcinoma characterized by neuroendocrine differentiation as well as methods and materials involved in treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation. For example, methods and materials for using ASCL1 and RET expression levels to identify lung cancer patients having lung adenocarcinoma characterized by neuroendocrine differentiation are provided.
Information query
Patent Agency Ranking
0/0